News
The drugs are how Pierre died, but the system caused him to relapse and die. If something isn’t done, we will keep losing our children,' says stepmom ...
SALEM: With a dedicated centre, longer treatment plans and new support activities, the Government Mohan Kumaramangalam ...
In a recently published study, researchers at Fox Chase Cancer Center revealed for the first time that cancer cells can evade ...
The vaccine ELI-002 2P showed favorable relapse-free survival and overall survival in patients with pancreatic and colorectal ...
A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...
Research shows that RPM can be especially valuable in behavioral health to catch early signs of worsening symptoms, enhance ...
23h
TipRanks on MSNElicio Therapeutics Publishes Promising Phase 1 Study Data
Elicio Therapeutics ( (ELTX) ) just unveiled an announcement. On August 12, 2025, Elicio Therapeutics announced the publication of follow-up data from its Phase 1 AMPLIFY-201 study in Nature Medicine ...
At extended median follow-up of 19.7 months, median overall survival (“OS”) increased from 16.33 to 28.94 months Clinical efficacy correlated with the magnitude of T cell responses specific to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results